Thomas Slavin

456 total citations
4 papers, 25 citations indexed

About

Thomas Slavin is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Thomas Slavin has authored 4 papers receiving a total of 25 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 2 papers in Cancer Research and 1 paper in Molecular Biology. Recurrent topics in Thomas Slavin's work include BRCA gene mutations in cancer (4 papers), Genomics and Rare Diseases (2 papers) and Cancer Genomics and Diagnostics (2 papers). Thomas Slavin is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Genomics and Rare Diseases (2 papers) and Cancer Genomics and Diagnostics (2 papers). Thomas Slavin collaborates with scholars based in United States, Peru and Mexico. Thomas Slavin's co-authors include Irene Rainville, Erin Mundt, Nanda Singh, Charité Ricker, Susan Manley, Kathleen R. Blazer, Jeffrey N. Weitzel, Ian K. Komenaka, Kevin C. Ward and Jill S. Dolinsky and has published in prestigious journals such as Cancer Research, JAMA Oncology and JCO Precision Oncology.

In The Last Decade

Thomas Slavin

4 papers receiving 25 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Slavin United States	3	19	8	8	7	7	4	25
Hanna Janiszewska Poland	3	22 1.2×	12 1.5×	8 1.0×	7 1.0×	8 1.1×	3	35
Henrique C.R. Galvão Brazil	2	12 0.6×	6 0.8×	7 0.9×	6 0.9×	9 1.3×	4	22
Lara Sucheston‐Campbell United States	3	15 0.8×	14 1.8×	8 1.0×	4 0.6×	12 1.7×	3	32
Vickie Hsuan United States	2	22 1.2×	15 1.9×	5 0.6×	9 1.3×	11 1.6×	2	29
Adolfo Ortiz Barboza Costa Rica	3	22 1.2×	15 1.9×	6 0.8×	5 0.7×	8 1.1×	6	32
Stephanie Nesci Australia	3	22 1.2×	4 0.5×	9 1.1×	6 0.9×	6 0.9×	3	32
Sarah K. Macklin‐Mantia United States	4	6 0.3×	12 1.5×	7 0.9×	7 1.0×	6 0.9×	6	22
Henriette Roed Nielsen Denmark	3	26 1.4×	12 1.5×	5 0.6×	3 0.4×	10 1.4×	6	29
Davide Bondavalli Italy	4	11 0.6×	15 1.9×	4 0.5×	12 1.7×	5 0.7×	7	33
Alex Stram Uganda	2	14 0.7×	12 1.5×	4 0.5×	4 0.6×	7 1.0×	2	27

Countries citing papers authored by Thomas Slavin

Since Specialization

Citations

This map shows the geographic impact of Thomas Slavin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Slavin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Slavin more than expected).

Fields of papers citing papers by Thomas Slavin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Slavin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Slavin. The network helps show where Thomas Slavin may publish in the future.

Co-authorship network of co-authors of Thomas Slavin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Slavin. A scholar is included among the top collaborators of Thomas Slavin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Slavin. Thomas Slavin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Mundt, Erin, Irene Rainville, Charité Ricker, et al.. (2023). Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants. Cancer Genetics. 278-279. 84–90. 12 indexed citations

2.

Kurian, Allison W., Paul Abrahamse, Kevin C. Ward, et al.. (2021). Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes. JCO Precision Oncology. 5(5). 1853–1859. 5 indexed citations

3.

Chávarri-Guerra, Yanin, Kai Yang, Ian K. Komenaka, et al.. (2018). Abstract P6-09-05: Factors associated with the uptake of risk-reducing surgeries among Hispanic women at high risk of breast and ovarian cancer. Cancer Research. 78(4_Supplement). P6–9. 1 indexed citations

4.

Blazer, Kathleen R., Thomas Slavin, & Jeffrey N. Weitzel. (2016). Increased Reach of Genetic Cancer Risk Assessment as a Tool for Precision Management of Hereditary Breast Cancer. JAMA Oncology. 2(6). 723–723. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact